Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update

NEXT STORY
Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board
PREV STORY
PDS Biotech Provides Business Update and Reports Second Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RespireRx Pharmaceuticals Inc. Secures Clinical and Commercial Supply of Dronabinol for Obstructive Sleep Apnea with the Signing of a Development and Supply Agreement with Noramco, Inc.

Glen Rock, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- September 10, 2018 /Globe Newswire ...

author_avatar
NASDAQ Market News

Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets for immune-mediated diseases

author_avatar
NASDAQ Market News

New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer

author_avatar
NASDAQ Market News